Topical Cyclosporine and Disease Progression

NCT00567983 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Disease Progression
Disease Severity
Staining
Schirmers
OSDI

Interventions

DRUG: Restasis
DRUG: Endura

Sponsor

Innovative Medical